Paul Hopper (I actually wonder if he still holds any shares here from the ones issued and bought years ago. )
Has always stipulated that small biotechs don't have the distribution and sales team to go door knock and convince clinics to prescribe new drugs, nor do we have a large enough target market (in PTX-100) to warrent running any "Ask Your Doctor" ads in the US.
So as much as SYC likes to talk about Oz company bringing a drug to market themselves and implying PTX could be the first, there is good reason for it.
Even NEU partnered with NASDAQ listed Acadia Pharmaceuticals for their Rett syndrome treatment.
Paul Hopper (I actually wonder if he still holds any shares here...
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.04M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.8¢ | 4.5¢ | $98.21K | 2.157M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 472315 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 868129 | 2 |
View Market Depth
| Last trade - 15.51pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.5¢ |
Change
0.000 ( 6.05 %) |
||||
| Open | High | Low | Volume | ||
| 4.7¢ | 4.7¢ | 4.5¢ | 1078953 | ||
| Last updated 15.39pm 06/05/2024 ? | |||||
| PTX (ASX) Chart |